DE602004022689D1 - Verwendung probiotischer bakterien zur behandlung von infektionen - Google Patents

Verwendung probiotischer bakterien zur behandlung von infektionen

Info

Publication number
DE602004022689D1
DE602004022689D1 DE602004022689T DE602004022689T DE602004022689D1 DE 602004022689 D1 DE602004022689 D1 DE 602004022689D1 DE 602004022689 T DE602004022689 T DE 602004022689T DE 602004022689 T DE602004022689 T DE 602004022689T DE 602004022689 D1 DE602004022689 D1 DE 602004022689D1
Authority
DE
Germany
Prior art keywords
infections
probiotic bacteria
treatment
cultures
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004022689T
Other languages
English (en)
Inventor
Paul Ross
Stephen Hallahan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Cork
Teagasc Agriculture and Food Development Authority
Original Assignee
University College Cork
Teagasc Agriculture and Food Development Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College Cork, Teagasc Agriculture and Food Development Authority filed Critical University College Cork
Publication of DE602004022689D1 publication Critical patent/DE602004022689D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE602004022689T 2003-10-17 2004-10-15 Verwendung probiotischer bakterien zur behandlung von infektionen Active DE602004022689D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE20030773A IE20030773A1 (en) 2003-10-17 2003-10-17 Use of probiotic bacteria in the treatment of infection
PCT/IE2004/000143 WO2005034970A1 (en) 2003-10-17 2004-10-15 Use of probiotic bacteria in the treatment of infection

Publications (1)

Publication Number Publication Date
DE602004022689D1 true DE602004022689D1 (de) 2009-10-01

Family

ID=34401258

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004022689T Active DE602004022689D1 (de) 2003-10-17 2004-10-15 Verwendung probiotischer bakterien zur behandlung von infektionen

Country Status (8)

Country Link
US (1) US9597362B2 (de)
EP (1) EP1675603B9 (de)
AT (1) ATE439851T1 (de)
DE (1) DE602004022689D1 (de)
DK (1) DK1675603T3 (de)
ES (1) ES2331650T3 (de)
IE (1) IE20030773A1 (de)
WO (1) WO2005034970A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2944753A1 (en) * 2004-02-02 2005-08-11 Bimeda Research & Development Limited Sequential delivery injector device
WO2006076780A1 (en) * 2004-12-17 2006-07-27 Gielen Cornelis Use of non-pathogenic bacterial strains in cleaning and milking an animal
EP2081606B1 (de) 2006-11-17 2015-03-18 SCA Hygiene Products AB Sanitärartikel mit einer mikroben unterdrückenden zusammensetzung
AU2006350772C1 (en) * 2006-11-17 2013-05-23 Essity Hygiene And Health Aktiebolag Hygiene tissue comprising a microbe-inhibiting composition
EP1997499A1 (de) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mikroorganismen aus der Muttermilch, Zusammensetzungen, die diese enthalten und deren Verwendung zur Behandlung von Mastitis
US20090280099A1 (en) * 2008-05-07 2009-11-12 Bachman Stephen E Nasopharyngeal inoculate of probiotics and prebiotics for treatment of respiratory infections
UA66800U (ru) * 2011-02-08 2012-01-25 Ольга Александровна Беляева Комплексный сорбционно-пробиотический препарат линесил для лечения гнойных ран
RU2528862C1 (ru) * 2013-04-19 2014-09-20 Вячеслав Михайлович Абрамов ШТАММ Lactobacillus fermentum, ОБЛАДАЮЩИЙ ШИРОКИМ СПЕКТРОМ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТИ И ПРОБИОТИЧЕСКИЙ КОНСОРЦИУМ ЛАКТОБАКТЕРИЙ ДЛЯ ИЗГОТОВЛЕНИЯ БАКТЕРИАЛЬНЫХ ПРЕПАРАТОВ
DE102013105666A1 (de) * 2013-06-03 2014-12-04 Hochschule Hannover Probiotische Stämme, Zusammensetzungen enthaltend probiotische Stämme sowie pharmazeutische Mittel
PL2862576T3 (pl) * 2013-10-16 2017-06-30 Casen Recordati, S.L. Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka
EP3196644B1 (de) * 2016-01-22 2019-11-27 Mastatix, Ltd. Verfahren zur diagnose von mastitis bei laktierenden tieren
WO2017173241A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
EP3436156A1 (de) 2016-03-31 2019-02-06 Gojo Industries, Inc. Antimikrobielle peptide stimulierende reinigungszusammensetzung
MY196871A (en) * 2016-09-15 2023-05-05 Kirin Holdings Kk Composition which contains lactic acid bacterium as effective component and which is for preventing or ameliorating skin condition deterioration caused by abnormal proliferation of specific bacterium in skin
AU2017365019A1 (en) 2016-11-23 2019-07-11 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11883445B2 (en) 2018-03-14 2024-01-30 Emory University Lactococcus bacteria and uses thereof
RU2709970C1 (ru) * 2019-07-05 2019-12-23 Илья Владимирович Кукес Способ лечения и профилактики острых и хронических форм мастита у животных

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
IES70514B2 (en) * 1995-04-12 1996-12-11 Teagasc Agric Food Dev Authori Bacteriocins
ES2193180T3 (es) * 1995-08-07 2003-11-01 Nestle Sa Bacteriocina.
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
EP0940303B1 (de) * 1997-09-19 2008-01-02 Nissan Motor Company, Limited Vorrichtung zum schützen der insassen eines fahrzeuges bei einem seitenaufprall
AU8455801A (en) * 2000-08-08 2002-02-18 Genesis Res & Dev Corp Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
SE520670C2 (sv) * 2001-12-18 2003-08-12 Sca Hygiene Prod Ab Andningsbart absorberande alster med konformade hålrum och metod för framställning
KR100467068B1 (ko) * 2002-03-06 2005-01-24 정명준 락토코쿠스 락티스 씨비티-19, 이를 이용한 항균 배양액분리 농축물의 제조 방법 및 이를 포함하는 화장료 조성물

Also Published As

Publication number Publication date
ATE439851T1 (de) 2009-09-15
EP1675603A1 (de) 2006-07-05
US9597362B2 (en) 2017-03-21
US20080233091A1 (en) 2008-09-25
WO2005034970A1 (en) 2005-04-21
EP1675603B1 (de) 2009-08-19
ES2331650T3 (es) 2010-01-12
EP1675603B9 (de) 2010-02-17
DK1675603T3 (da) 2009-11-30
IE20030773A1 (en) 2005-04-20

Similar Documents

Publication Publication Date Title
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
ATE332142T1 (de) Zusammensetzungen zur behandlung von tierischen krankheiten und syndromen mit transferfaktor
ATE419859T1 (de) Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
HUP0203523A2 (hu) Bakteriofágokkal társuló lizáló enzimek használata különböző betegségek megelőzésére és kezelésére
ATE481134T1 (de) Zusammensetzungen und verwendung von tyrosinkinase-hemmern zur behandlung von pathogenen infektionen
ATE369140T1 (de) Stickstoffoxid zur behandlung therapieresistenter organismen
DE60216614D1 (de) Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln
ATE439138T1 (de) Probiotika zur primären prävention atopischer erkrankungen
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE388711T1 (de) C-kithemmer zur behandlung von bakteriellen infektionen
ATE445644T1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
DE60236318D1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
ATE433459T1 (de) Desoxo-nonadepsipeptide
ATE346147T1 (de) Zusammensetzungen und methoden zur wundheilung
ATE455789T1 (de) Substituierte nonadepsipeptide
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
DE60219658D1 (de) Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
ATE290393T1 (de) Milchsäurebakterien zur behandlung und prophylaxe von giardiasis
DE60318558D1 (de) Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen
RS57471B1 (sr) Nova probiotička starter kultura za humanu i animalnu primenu
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
ATE375152T1 (de) Behandlung von gastrointestinalen erkrankungen mit n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2- amine
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition